Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-12

FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride) from Kenvue Brands LLC, under the existing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ZYRTEC-D (CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)